Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for 05433_FLUKA

    Client Email Product

    05433_FLUKA

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    30
    US DMFs Filed

    US DMFs Filed

    18
    CEP/COS Certifications

    CEP/COS Certifications

    4
    JDMFs Filed

    JDMFs Filed

    5
    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    8
    API REF. PRICE (USD / KG)

    0

    API Market Place

    26
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    602
    Europe

    Europe

    303
    Canada

    Canada

    166
    Australia

    Australia

    3
    South Africa

    South Africa

    184
    Uploaded Dossiers

    Uploaded Dossiers

    35
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    4,014.00

    Annual Reports

    0

    FDF Market Place

    14
    EXCIPIENTS
    326
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    16

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    86
    REF STANDARD

    EDQM

    0

    USP

    1

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;INJECTION - 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML
    • INJECTABLE;INJECTION - 20MG/100ML;5GM/100ML;30MG/100ML;600MG/100ML;310MG/100ML
    • CAPSULE, EXTENDED RELEASE;ORAL - 10MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • CAPSULE, EXTENDED RELEASE;ORAL - 8MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 10MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 20MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET, EXTENDED RELEASE;ORAL - 8MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • INJECTABLE;INJECTION - 5GM/100ML;149MG/100ML;450MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;224MG/100ML;450MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;298MG/100ML;450MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;74.5MG/100ML;450MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;149MG/100ML;225MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;298MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • INJECTABLE;INJECTION - 5GM/100ML;74.5MG/100ML;225MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML
    • TABLET, EXTENDED RELEASE;ORAL - 10MEQ
    • TABLET, EXTENDED RELEASE;ORAL - 8MEQ
    • SOLUTION;IRRIGATION - 20MG/100ML;30MG/100ML;600MG/100ML;310MG/100ML
    • INJECTABLE;INJECTION - 20MG/100ML;5GM/100ML;104MG/100ML;600MG/100ML;310MG/100ML
    • INJECTABLE;INJECTION - 20MG/100ML;5GM/100ML;179MG/100ML;600MG/100ML;310MG/100ML
    • INJECTABLE;INJECTION - 20MG/100ML;5GM/100ML;254MG/100ML;600MG/100ML;310MG/100ML
    • INJECTABLE;INJECTION - 20MG/100ML;5GM/100ML;328MG/100ML;600MG/100ML;310MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;149MG/100ML;900MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;224MG/100ML;900MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;298MG/100ML;900MG/100ML
    • INJECTABLE;INJECTION - 5GM/100ML;74.5MG/100ML;900MG/100ML
    • FOR SOLUTION;ORAL - 420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT
    • INJECTABLE;INJECTION - 1.49GM/100ML
    • INJECTABLE;INJECTION - 14.9MG/ML
    • INJECTABLE;INJECTION - 2.24GM/100ML
    • INJECTABLE;INJECTION - 2.98GM/100ML
    • INJECTABLE;INJECTION - 29.8MG/ML
    • INJECTABLE;INJECTION - 745MG/100ML
    • INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)
    • SOLUTION;IRRIGATION - 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6.4MG/ML;1.7MG/ML
    • FOR SOLUTION;ORAL - 10MEQ
    • FOR SOLUTION;ORAL - 20MEQ
    • FOR SOLUTION;ORAL - 40MEQ
    • INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)
    • INJECTABLE;INJECTION - 2MEQ/ML
    Full View ScreenFull Screen View
    Rising Pharmaceuticals' Generic Potassium Chloride Receives Approval in the U.S.
    Rising Pharmaceuticals' Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217412

    FDA
    19 Dec 2023
    Share Share
    Nexus Receives FDA Approval for Potassium Chloride for Injection Concentrate
    Nexus Receives FDA Approval for Potassium Chloride for Injection Concentrate

    https://www.businesswire.com/news/home/20230815518834/en

    BUSINESSWIRE
    15 Aug 2023
    Share Share
    Nexus' Generic Potassium Chloride Receives Approval in the U.S.
    Nexus' Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217704

    FDA
    14 Aug 2023
    Share Share
    Rubicon's Generic Potassium Chloride Receives Approval in the U.S.
    Rubicon's Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216321

    FDA
    16 Jun 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride
    FDA Confirms Paragraph IV Patent Litigation for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-sodium-sulfate-magnesium-sulfate-and-potassium-chloride-91224.pdf

    FDA
    25 Apr 2023
    Share Share
    Guardian's Generic Potassium Chloride Receives Approval in the U.S.
    Guardian's Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214892

    FDA
    30 Dec 2022
    Share Share
    Strides Pharma Arms Gets USFDA Approval For Potassium-Deficiency Drug
    Strides Pharma Arms Gets USFDA Approval For Potassium-Deficiency Drug

    https://health.economictimes.indiatimes.com/news/pharma/strides-pharma-arms-gets-usfda-approval-for-potassium-deficiency-drug/95600319

    ECONOMICTIMES
    18 Nov 2022
    Share Share
    HengRui's Generic Potassium Chloride Receives Approval in the U.S.
    HengRui's Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211665

    FDA
    17 Nov 2022
    Share Share
    Rubicon Generic Potassium Chloride Receives Approval in the U.S.
    Rubicon Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215725

    FDA
    25 Jul 2022
    Share Share
    Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US
    Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215371

    FDA
    08 Jun 2022
    Share Share
    WES Pharma Generic Potassium Chloride Receives Approval in the U.S
    WES Pharma Generic Potassium Chloride Receives Approval in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213062

    FDA
    06 Jun 2022
    Share Share
    Rubicon Research ’s Generics Potassium Chloride Receives Approvals In US
    Rubicon Research ’s Generics Potassium Chloride Receives Approvals In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214108

    FDA
    24 Mar 2022
    Share Share
    Fresenius Kabi's Generic Cardioplegic Receives Approval in the U.S.
    Fresenius Kabi's Generic Cardioplegic Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214623

    FDA
    18 Feb 2022
    Share Share
    Granules' Generic Potassium Chloride Receives Approval in the U.S.
    Granules' Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213467

    FDA
    27 Jan 2022
    Share Share
    Tris Pharma's Generic Potassium Chloride Receives Approval in U.S.
    Tris Pharma's Generic Potassium Chloride Receives Approval in U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214076

    FDA
    26 Jan 2022
    Share Share
    Rubicon's Generic Potassium Chloride Receives Approval in the U.S.
    Rubicon's Generic Potassium Chloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214656

    FDA
    13 Jan 2022
    Share Share
    Fresenius Kabi`s Generic Testosterone Receives Approval In US
    Fresenius Kabi`s Generic Testosterone Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211428

    FDA
    15 Nov 2021
    Share Share
    Enforcement Report - Week of October 20, 2021
    Enforcement Report - Week of October 20, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-20-2021-1634716803.pdf

    FDA
    20 Oct 2021
    Share Share
    Saptalis Pharms Generic Potassium Chloride Receives Approval in US
    Saptalis Pharms Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211648

    FDA
    30 May 2021
    Share Share
    Strides Pharma`s Generic Potassium Chloride API Receives Approval In US
    Strides Pharma`s Generic Potassium Chloride API Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211667

    FDA
    16 Mar 2021
    Share Share
    Strides receives US FDA approval for potassium chloride for oral solution
    Strides receives US FDA approval for potassium chloride for oral solution

    http://www.pharmabiz.com/NewsDetails.aspx?aid=136138&sid=2

    PHARMABIZ
    15 Mar 2021
    Share Share
    Enforcement Report for Week of October 7, 2020
    Enforcement Report for Week of October 7, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-october-7-2020-1602054141.pdf

    FDA
    07 Oct 2020
    Share Share
    Zydus Pharms's Generic Potassium Chloride Receives Approval In US
    Zydus Pharms's Generic Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210395

    FDA
    21 Sep 2020
    Share Share
    Fresenius Kabi USA's Generic Potassium Cl: Sodium Cl Receives Approval In US
    Fresenius Kabi USA's Generic Potassium Cl: Sodium Cl Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212347

    FDA
    21 Sep 2020
    Share Share
    Zydus Cadila gets US FDA nod for potassium chloride extended-release tablets
    Zydus Cadila gets US FDA nod for potassium chloride extended-release tablets

    https://www.expresspharma.in/drug-approvals/zydus-cadila-gets-us-fda-nod-for-potassium-chloride-extended-release-tablets/#:~:text=It%20is%20a%20mineral%20supplement,of%20potassium%20in%20the%20blood&text=Zydus%20Cadila%20has%20received%20final,20%20mEq%20(1500%20mg).

    EXPRESS PHARMA
    18 Sep 2020
    Share Share
    Zydus Cadila receives US FDA approval for potassium chloride ER tablets
    Zydus Cadila receives US FDA approval for potassium chloride ER tablets

    http://www.pharmabiz.com/NewsDetails.aspx?aid=131204&sid=2

    PHARMABIZ
    17 Sep 2020
    Share Share
    Fresenius Kabi USA's Generic Dextrose Potassium Chloride Receives Approval In US
    Fresenius Kabi USA's Generic Dextrose Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212346

    FDA
    15 Sep 2020
    Share Share
    Fresenius Kabi's Generic Potassium Chloride Receives Approval In US
    Fresenius Kabi's Generic Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211087

    FDA
    09 Sep 2020
    Share Share
    Fresenius Kabi's Generic Potassium Chloride Receives Approval In US
    Fresenius Kabi's Generic Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211087

    FDA
    09 Sep 2020
    Share Share
    Fresenius Kabi's Generic Potassium Chloride Receives Approval In US
    Fresenius Kabi's Generic Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211087

    FDA
    09 Sep 2020
    Share Share
    Centaur Pharms's Generic Potassium Chloride Receives Approval In US
    Centaur Pharms's Generic Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213588

    FDA
    21 Aug 2020
    Share Share
    PharMEDium Services Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products
    PharMEDium Services Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products

    https://www.pharmacompass.com/pdf/news/pharmedium-services-issues-voluntary-nationwide-recall-of-certain-lots-of-compounded-sterile-products-1587014091.pdf

    FDA
    15 Apr 2020
    Share Share
    Yung Shin Pharma`s Generic Granisetron Hydrochloride Receives Approval in US
    Yung Shin Pharma`s Generic Granisetron Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202647

    FDA
    11 Mar 2020
    Share Share
    Granules India`s Generic Potassium Chloride Receives Approval in US
    Granules India`s Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211797

    FDA
    06 Mar 2020
    Share Share
    Yichang Humanwell`s Generic Potassium Chloride Receives Approval in US
    Yichang Humanwell`s Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212561

    FDA
    01 Oct 2019
    Share Share
    Strides receives FDA warning letter and defers 10 ANDAs
    Strides receives FDA warning letter and defers 10 ANDAs

    https://www.in-pharmatechnologist.com/Article/2019/07/02/Strides-facility-receives-warning-letter

    Ben Hargreaves IN PHARMATECHNOLOGIST
    03 Jul 2019
    Share Share
    PII's Generic Potassium Chloride 10 MEQ Tablet (Extended Release Oral) Receives Approval in US
    PII's Generic Potassium Chloride 10 MEQ Tablet (Extended Release Oral) Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210097

    FDA
    17 Jun 2019
    Share Share
    Prinston Pharmaceutical's Generic Potassium Chloride Receives Approval in US
    Prinston Pharmaceutical's Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209026

    FDA
    11 Jun 2019
    Share Share
    Belcher Pharm’s Generic Potassium Chloride Receives Approval In US
    Belcher Pharm’s Generic Potassium Chloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212183

    FDA
    09 May 2019
    Share Share
    Strides arm and its partner get USFDA nod for hypokalemia treatment drug
    Strides arm and its partner get USFDA nod for hypokalemia treatment drug

    https://www.moneycontrol.com/news/business/strides-arm-and-its-partner-get-usfda-nod-for-hypokalemia-treatment-drug-3745871.html

    MONEYCONTROL
    02 Apr 2019
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Plenvu 209381 (Polyethylene Glycol 3350 For Oral Solution)
    FDA Confirms Paragraph IV Patent Challenge of Plenvu 209381 (Polyethylene Glycol 3350 For Oral Solution)

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-plenvu-209381-polyethylene-glycol-3350-for-oral-solution-1550147296.pdf

    FDA
    13 Feb 2019
    Share Share
    Pii's Generic Potassium Chloride Receives Approval in US
    Pii's Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206881

    FDA
    26 Jan 2019
    Share Share
    Strides Pharma's Generic Polyethylene Glycol 3350 & Electrolytes Receives in US
    Strides Pharma's Generic Polyethylene Glycol 3350 & Electrolytes Receives in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204558

    FDA
    21 Dec 2018
    Share Share
    Aurobindo Pharma's Generic Potassium Chloride Receives Approval in US
    Aurobindo Pharma's Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210921

    FDA
    19 Dec 2018
    Share Share
    Epic Pharma Generic Potassium Chloride Receives Approval in US
    Epic Pharma Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210200

    FDA
    27 Nov 2018
    Share Share
    Novel Labs' Generic Potassium Chloride Receives Approval in US
    Novel Labs' Generic Potassium Chloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210241

    FDA
    20 Nov 2018
    Share Share
    EMA Approved bendroflumethiazide, KCl Nationally authorised medicinal products
    EMA Approved bendroflumethiazide, KCl Nationally authorised medicinal products

    https://www.ema.europa.eu/documents/psusa-products/bendroflumethiazide-bendroflumethiazide/potassium-chloride-list-nationally-authorised-medicinal-products-psusa-00010583-201801_en.pdf

    EMA
    19 Nov 2018
    Share Share
    How the Timing of Commercialization Caused Apotex to Lose its 180 Days
    How the Timing of Commercialization Caused Apotex to Lose its 180 Days

    https://www.raps.org/news-and-articles/news-articles/2018/10/cgt-exclusivity-how-a-slight-delay-in-commerciali?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2015%20October

    Zachary Brennan RAPS
    16 Oct 2018
    Share Share
    CGT exclusivity for ANDA 211067 and request to rescind approval of ANDA 209786
    CGT exclusivity for ANDA 211067 and request to rescind approval of ANDA 209786

    https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM623290.pdf

    FDA
    15 Oct 2018
    Share Share
    Strides hamstrung by US FDA Form 483
    Strides hamstrung by US FDA Form 483

    https://www.in-pharmatechnologist.com/Article/2018/09/20/Strides-hamstrung-by-US-FDA-Form-483

    Ben Hargreaves IN-PHARMATECHNOLOGIST
    21 Sep 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search